Results 31 to 40 of about 6,648 (196)

New fluorogenic probes for neutral and alkaline ceramidases

open access: yesJournal of Lipid Research, 2019
New fluorogenic ceramidase substrates derived from the N-acyl modification of our previously reported probes (RBM14) are reported. While none of the new probes were superior to the known RBM14C12 as acid ceramidase substrates, the corresponding nervonic ...
Mireia Casasampere   +9 more
doaj   +1 more source

Acid ceramidase gene therapy ameliorates pulmonary arterial hypertension with right heart dysfunction

open access: yesRespiratory Research, 2023
Background Up-regulation of ceramides in pulmonary hypertension (PH), contributing to perturbations in sphingolipid homeostasis and the transition of cells to a senescence state. We assessed the safety, feasibility, and efficiency of acid ceramidase gene
Michael G. Katz   +7 more
doaj   +1 more source

Anxiety and Depression Are Related to Higher Activity of Sphingolipid Metabolizing Enzymes in the Rat Brain

open access: yesCells, 2020
Changes in sphingolipid metabolism have been suggested to contribute to the pathophysiology of major depression. In this study, we investigated the activity of acid and neutral sphingomyelinases (ASM, NSM) and ceramidases (AC, NC), respectively, in ...
Iulia Zoicas   +5 more
doaj   +1 more source

Potential role of autophagy induced by FLT3-ITD and acid ceramidase in acute myeloid leukemia chemo-resistance: new insights

open access: yesCell Communication and Signaling, 2022
Acute myeloid leukemia (AML) is a type of leukemia with a poor prognosis and survival characterized by abnormal cell proliferation and differentiation.
Hamidreza Zalpoor   +9 more
doaj   +1 more source

Potent Inhibition of Acid Ceramidase by Novel B-13 Analogues [PDF]

open access: yes, 2011
The lipid-signalling molecule ceramide is known to induce apoptosis in a variety of cell types. Inhibition of the lysosomal acid ceramidase can increase cellular ceramide levels and thus induce apoptosis.
Jan Jasper Klein   +2 more
core   +1 more source

Targeting Acid Ceramidase to Attenuate Kidney Fibrosis [PDF]

open access: yes, 2022
Chronic kidney disease (CKD) affects nearly 1 in 10 Canadians, a condition that in its end-stage has a worse prognosis than most cancers, and results in an annual healthcare cost of $40 billion.
Ki, Seung Hyun
core   +1 more source

Cell-nonautonomous function of ceramidase in photoreceptor homeostasis

open access: yes, 2011
Neutral ceramidase, a key enzyme of sphingolipid metabolism, hydrolyzes ceramide to sphingosine. These sphingolipids are critical structural components of cell membranes and act as second messengers in diverse signal transduction cascades.
Acharya, Jairaj K.   +10 more
core   +2 more sources

The crystal structure of human transport and Golgi organization 2 homolog (TANGO2) suggests a cysteine N-terminal nucleophile (Ntn) hydrolase. [PDF]

open access: yesActa Crystallogr D Struct Biol
This study reports the first crystal structure of human TANGO2, mutations of which are responsible for TANGO2 deficiency disorder. The crystallographic analysis demonstrates that interactions between heme and TANGO2 are nonspecific, helping to address ongoing questions about the role of TANGO2 as a heme‐trafficking protein.Recently, there has been ...
Zhou D, Chen L, Rose J, Wang BC.
europepmc   +2 more sources

Divergent Atrial Transcriptomic Signatures in Diabetic and Nondiabetic Atrial Fibrillation. [PDF]

open access: yesJ Arrhythm
Diabetes alters the atrial transcriptome in atrial fibrillation, characterized by enhanced mitochondrial ATP synthesis, suppressed immune and inflammatory pathways, and distinct miRNA expression profiles, suggesting metabolic and epigenetic remodeling of the atrial substrate.
Yoshimura K   +9 more
europepmc   +2 more sources

Unraveling A4GALT Mechanism and Its Modulation With Adamantyl‐Galactosylceramide Analogues: Advancing Fabry Disease Therapeutic Strategies

open access: yesAngewandte Chemie, Volume 138, Issue 41, 5 October 2026.
A 310‐helix‐mediated conformational switch promotes a front‐face SNi‐like catalysis by human A4GALT. Mechanism‐guided design identifies AdaGalCer as a selective modulator of globotriaosylceramide (Gb3) biosynthesis, opening a clear route toward new Fabry disease therapeutics.
Nicky de Koster   +13 more
wiley   +2 more sources

Home - About - Disclaimer - Privacy